MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
about
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancerMicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cellsMicroRNAs: control and loss of control in human physiology and diseaseAberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinomamiR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressormiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancermiR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cellsMicroRNA miR-155 is a biomarker of early pancreatic neoplasiaEnjoy the Silence: The Story of let-7 MicroRNA and CancerTumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentThe Role of Mir-148a in CancerThe Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaManaging Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene TherapyExpression and Function of miR-155 in Diseases of the Gastrointestinal TractNon-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we haveDiagnostic and therapeutic biomarkers in pancreaticobiliary malignancyMicroRNA in pancreatic ductal adenocarcinoma and its precursor lesionsmiRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A ReviewRoles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseEmerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)Circulating RNAs as new biomarkers for detecting pancreatic cancerThe Role of microRNAs in Stemness of Cancer Stem CellsEarly diagnosis of pancreatic cancer: challenges and new developmentsThe miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and diseaseCurrent status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinomaMiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancerCancer chemoprevention with dietary isothiocyanates mature for clinical translational researchIdentification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissuesOverexpression of microRNA miR-30a or miR-191 in A549 lung cancer or BEAS-2B normal lung cell lines does not alter phenotypeTissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancerRepression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathwayMiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinomaDiagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissueSerum microRNA biomarkers for detection of non-small cell lung cancerMicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumorsNoncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?MicroRNAs in cancer.Pancreatic cancer.Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer.A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
P2860
Q21195215-68CB49B8-AE6A-4752-84EA-BB33CE0D3C73Q24596316-A8B690AE-F0C6-45BA-B371-38BFAA2EA1B7Q24618771-961D3854-A412-46FC-A2AB-8111D99AB29FQ24627680-2082CD2F-5D00-4910-AE01-8417CAF296BFQ24628906-880B67A5-8479-4C1C-8658-13A8F169DA1AQ24632886-AAB417BF-C3B1-4832-8B98-AA5EDB521C19Q24645027-AA04FF51-0FA7-401C-9607-47F25F542A22Q24649254-9EF8E1EB-80C9-46C4-928B-4B03972833DEQ24653610-3D46FEFC-6F3B-4284-8BB2-3B34E7B50A05Q24674155-9D71AE25-2A6E-403C-8332-574C699BA5A5Q26743549-CDA01DFE-3109-4C02-BE1B-DDC21E11B617Q26744298-960855AA-B7C7-4D7D-8188-A56D7AD2DAB3Q26749037-0724ED16-6939-4877-8845-512B68EC85B3Q26749058-861A70EE-7EB5-460C-9689-C0F5872FFE2CQ26750944-278522DA-A3DC-47A5-89A2-B5286D632594Q26767120-D11C1BFE-DA26-46F4-B8F0-FA6A9601FB01Q26769953-8B3A1AAD-ECA9-40EF-B22B-AE6A67284776Q26774628-84566D3A-99D7-4FD8-BD23-EEC352297BE3Q26795757-21E456D2-96B6-43A5-866D-C7FA176726B8Q26796523-CC01FECD-EF2C-402C-B959-7E0BF5EBEF50Q26801191-8DBAE7E8-680A-4CBA-B0AC-22F029FF3BB8Q27005618-A56EBA37-9B22-4841-AEEF-930A2B0ABB85Q27014027-191597CA-9756-425A-8236-FF8654D1048FQ27015587-7B24D4C5-73B2-4ED9-A27E-333E9176B9D5Q27026846-50F790DC-1337-4A9E-8606-7AD4DB0E1DBCQ27332271-E8DD8DA3-02BE-4B0F-B3F8-6B1A12CB972DQ28269727-53B80AA3-0F75-4155-A0FE-A4714A707C2CQ28390088-F2115770-8A0A-4576-9B67-C7069E33545CQ28472883-32699EB9-F57E-4D5F-A6BB-4C5E87D7DFE9Q28478758-202CE146-00C3-4072-BB7C-ADA4903EE478Q28587965-9A53F894-2533-4BBD-8108-DDF8E85106F5Q28658442-5AC683AC-BD9B-4D03-9D84-65A1D7DD6D5AQ28730615-192ED626-82A5-4A7C-9EB5-44FA4BE5E5A6Q28731643-8E390636-0BFB-4F97-B8AB-9903E64C9B29Q28731854-EC58ED10-BC4B-4796-8BCC-354BEBA8663AQ30241331-859EB096-C408-4E93-8408-237AFAB5EA96Q30437444-050DA085-F8DA-47F3-B7D7-E85D18745423Q30490247-D4D40A66-F558-4AFF-A53E-E43B35A37644Q30491447-86E9CE23-57E7-49D6-BA43-F57649BD0C74Q30493254-428A12D9-D2D8-41CC-AD0B-9F062C41B796
P2860
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@ast
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@en
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@nl
type
label
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@ast
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@en
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@nl
prefLabel
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@ast
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@en
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@nl
P2093
P356
P1433
P1476
MicroRNA expression alteration ...... creatic ductal adenocarcinoma.
@en
P2093
Davison TS
Labourier E
Maghnouj A
Szafranska AE
P2888
P304
P356
10.1038/SJ.ONC.1210228
P407
P577
2007-01-22T00:00:00Z
P5875
P6179
1047565364